10/18/2024

Janusmed sex and gender

Janusmed sex and gender – baloxavir marboxil

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Baloxavir marboxil

Baloxavir marboxil

Class : A

  1. EPAR Xofluza. EMA [www]. [updated 2022-08-01, cited 2023-01-11].
  2. Retout S, De Buck S, Jolivet S, Duval V, Cosson V. Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B. Clin Pharmacol Ther. 2022;112(2):372-381.
  3. Nezu K, Hayashida S, Nagano N, Udagawa S, Morioka I. Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir. Medicina (Kaunas). 2023;59(9):.
  4. Fujiwara N, Fujiwara T, Ise Y. Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan. J Pharm Health Care Sci. 2023;9(1):3.
  5. GUPS. Stockholm: Region Stockholm. 2022 [cited 2023-06-20.]